FGF21 mutants and uses thereof

Details for Australian Patent Application No. 2010246108 (hide)

Owner Amgen Inc.

Inventors Belouski, Edward John; Ellison, Murielle Marie; Hamburger, Agnes Eva; Hecht, Randy Ira; Li, Yue-Sheng; Michaels, Mark Leo; Sun, Jeonghoon; Xu, Jing

Agent Shelston IP

Pub. Number AU-A-2010246108

PCT Pub. Number WO2010/129503

Priority 61/175,736 05.05.09 US; 61/285,118 09.12.09 US

Filing date 4 May 2010

Wipo publication date 11 November 2010

International Classifications

C07K 14/50 (2006.01) Peptides having more than 20 amino acids

A61K 38/18 (2006.01) Medicinal preparations containing peptides - Growth factors

Event Publications

24 November 2011 PCT application entered the National Phase

  PCT publication WO2010/129503 Priority application(s): WO2010/129503

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010246114-Vinyl indazolyl compounds

2010246105-Nematocidal sulfonamides